Arzu Funda Tarhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arzu Funda Tarhan has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Aykut Şahin
Department of Cardiovascular Surgery, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir 26040, Türkiye
1 shared publication - Fatih Enes Durmaz
Department of Cardiology, Eskisehir City Hospital
1 shared publication - Mert Çelik
Department of Cardiovascular Surgery, Burdur State Hospital, Burdur 15100, Türkiye
1 shared publication
Latest Publications
- Open Access
- 9 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4466
Preoperative Serum Albumin-to-Creatinine Ratio Predicts 1-Year Reintervention After Above-Knee Femoropopliteal Bypass Surgery
Objective: Serum albumin/creatinine ratio (sACR) integrates nutritional–inflammatory status and renal reserve. We evaluated its ability to predict 1-year reintervention for symptomatic graft occlusion in patients undergoing prosthetic above-knee femoropopliteal bypass for peripheral artery disease (PAD). Methods: This single-center retrospective study included 132 adults (7 women, 125 men) who underwent Dacron above-knee femoropopliteal bypass. The primary analysis evaluated preoperative sACR as a continuous variable. For descriptive comparisons and Kaplan–Meier visualization, patients were stratified according to the median preoperative sACR value (3.77), yielding two groups: p < 0.001). The optimal cutoff was ≤3.7 (sensitivity 90.9%, specificity 64.6%). Higher sACR was associated with lower 1-year event risk in both univariate and multivariate models (adjusted HR 0.61, 95% CI 0.43–0.87; p = 0.007). Conclusions: Preoperative sACR is a practical biomarker associated with early and 1-year reintervention risk after prosthetic above-knee femoropopliteal bypass and may aid perioperative risk stratification.
- 9 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4466
Open AccessPreoperative Serum Albumin-to-Creatinine Ratio Predicts 1-Year Reintervention After Above-Knee Femoropopliteal Bypass Surgery
Objective: Serum albumin/creatinine ratio (sACR) integrates nutritional–inflammatory status and renal reserve. We evaluated its ability to predict 1-year reintervention for symptomatic graft occlusion in patients undergoing prosthetic above-knee femoropopliteal bypass for peripheral artery disease (PAD). Methods: This single-center retrospective study included 132 adults (7 women, 125 men) who underwent Dacron above-knee femoropopliteal bypass. The primary analysis evaluated preoperative sACR as a continuous variable. For descriptive comparisons and Kaplan–Meier visualization, patients were stratified according to the median preoperative sACR value (3.77), yielding two groups: p < 0.001). The optimal cutoff was ≤3.7 (sensitivity 90.9%, specificity 64.6%). Higher sACR was associated with lower 1-year event risk in both univariate and multivariate models (adjusted HR 0.61, 95% CI 0.43–0.87; p = 0.007). Conclusions: Preoperative sACR is a practical biomarker associated with early and 1-year reintervention risk after prosthetic above-knee femoropopliteal bypass and may aid perioperative risk stratification.